Related references
Note: Only part of the references are listed.Relation of Improvement in Glomerular Filtration Rate With Atorvastatin to Reductions in Heart Failure Morbidity
Vasilios G. Athyros et al.
AMERICAN JOURNAL OF CARDIOLOGY (2012)
Relation of Improvement in Estimated Glomerular Filtration Rate With Atorvastatin to Reductions in Hospitalizations for Heart Failure (from the Treating to New Targets [TNT] Study)
Jennifer E. Ho et al.
AMERICAN JOURNAL OF CARDIOLOGY (2012)
Impact of a High Loading Dose of Atorvastatin on Contrast-Induced Acute Kidney Injury
Cristina Quintavalle et al.
CIRCULATION (2012)
Short-Term, High-Dose Atorvastatin Pretreatment to Prevent Contrast-Induced Nephropathy in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention (from the ARMYDA-CIN [Atorvastatin for Reduction of MYocardial Damage during Angioplasty Contrast-Induced Nephropathy] Trial
Giuseppe Patti et al.
AMERICAN JOURNAL OF CARDIOLOGY (2011)
Contrast-induced acute kidney injury
Peter A. McCullough
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Epidemiology and prognostic implications of contrast-induced nephropathy
Peter A. McCullough et al.
AMERICAN JOURNAL OF CARDIOLOGY (2006)
Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention - Results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study
V Pasceri et al.
CIRCULATION (2004)